drugset / Trial / NCT05856305

SCRT in TNT With or Without Chlorophyllin

NCT05856305 ↗

Phase 2 Active not recruiting 76 enrolled Tata Memorial Centre
RandomizedSequentialQuadruple-blindTreatment

Summary

The goal of this clinical trial is to see, if addition of chlorophyllin to neoadjuvant Chemo-radiotherapy can reduce the gastro-intestinal/genitourinary/hematological toxicity rates and improve the quality of life in patient's diagnosed with locally advanced rectal cancer. This is a randomized placebo control trial, wherein participants randomized to Chlorophyllin arm will receive the drug of interest along with the standard treatment. Participants randomized to other arm will receive placebo along with the standard treatment. Researchers will compare the difference between the outcomes from both the arms and will also observe the non-operative management success rates.

Timeline

Start
2023-07-05
Primary completion
2025-09-09
Completion
2027-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject CHLOROPHYLLIN COPPER COMPLEX Unknown 750 mg Oral

Indications